Table 3.
Associations between serum hsa_circ_0007534 concentrations and clinicopathologic characteristics in patients with OC
| Characteristics | Case | hsa_circ_0007534 | p | |
|---|---|---|---|---|
|
| ||||
| Low | High | |||
| Age | 0.835 | |||
| < 50 | 35 | 18 | 17 | |
| ≥ 50 | 67 | 33 | 34 | |
| Histology | 0.421 | |||
| Serous | 60 | 32 | 28 | |
| Others | 42 | 19 | 23 | |
| Serum CA-125 (U/mL) | < 0.05 | |||
| < 35 | 29 | 19 | 10 | |
| ≥ 35 | 73 | 32 | 41 | |
| Tumor size | < 0.05 | |||
| < 5 cm | 40 | 34 | 6 | |
| ≥ 5 cm | 62 | 17 | 45 | |
| Histological grade | < 0.05 | |||
| Well | 44 | 32 | 12 | |
| Moderate/poor | 58 | 19 | 39 | |
| Lymph node metastasis | < 0.05 | |||
| Negative | 38 | 31 | 7 | |
| Positive | 64 | 20 | 44 | |
| FIGO stage | < 0.05 | |||
| I/II | 47 | 36 | 11 | |
| III/IV | 55 | 15 | 40 | |
OC, Ovarian cancer; FIGO, Federation Internationale of Gynecology and Obstetrics.